Novo Nordisk A/S

10-Year Study

NOV.XETRA · Healthcare · DE · Common Stock

Executive Summary: Novo Nordisk A/S has compounded at 8.3% annually over the last 10 years, with a maximum drawdown of 76.2% and an annualized volatility of 53.2%.

1Y CAGR
-47.0%
3Y CAGR
-22.3%
5Y CAGR
+2.7%
10Y CAGR
+8.3%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
76.2%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.32
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
0.36
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
29.3%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2021 · +73.7%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · -45.9%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
70%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
202612.9-35.7-3.010.9————————-21.8%
2025-2.55.9-25.9-7.46.8-6.1-27.614.4-3.4-8.0-0.43.9-45.9%
202412.54.39.7-0.23.68.4-9.23.0-15.4-3.1-1.3-17.4-9.8%
2023-0.25.010.53.5-0.7-1.9-0.617.60.95.32.60.649.6%
2022-10.33.710.78.6-6.43.57.8-6.7-3.47.87.96.730.6%
2021-1.63.11.64.06.19.110.18.6-0.913.20.14.373.7%
20205.8-4.66.35.50.6-0.9-4.40.17.0-6.31.92.813.3%
20193.74.910.3-6.4-2.95.9-3.310.20.13.53.13.135.4%
2018-0.4-4.826.4-2.23.7-2.38.0-0.5-3.8-5.97.0-3.319.5%
2017-3.11.2-2.210.95.6-0.8-3.611.91.65.31.03.934.9%
2016———2.22.9-3.75.8-17.2-11.5-12.2-2.17.4-27.5%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 53.2%. The dominant macroeconomic risk driver is QUAL.US, accounting for 35.8% of variance. Idiosyncratic stock-specific factors contribute 25.6%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2016-03-0110000
2016-04-0110224.445628063457
2016-05-0110515.975485602174
2016-06-0110130.055757445
2016-07-0110715.20553394327
2016-08-018872.378152790232
2016-09-017856.00151023793
2016-10-016895.719419367453
2016-11-016752.786186716648
2016-12-017250.355647548224
2017-01-017024.83127810627
2017-02-017108.501156275915
2017-03-016953.566925789334
2017-04-017709.360104098542
2017-05-018142.339924892632
2017-06-018076.536700804337
2017-07-017782.781939172471
2017-08-018712.522164764261
2017-09-018855.455397415066
2017-10-019325.651795767288
2017-11-019416.198650224851
2017-12-019781.689713526743
2018-01-019745.686720019417
2018-02-019275.490321667196
2018-03-0111721.60381874448
2018-04-0111459.537085105952
2018-05-0111882.673390821259
2018-06-0111614.741000937156
2018-07-0112547.380343983656
2018-08-0112487.645040149404
2018-09-0112007.26802003762
2018-10-0111299.20914772689
2018-11-0112085.611612650939
2018-12-0111686.477302607183
2019-01-0112121.075235469016
2019-02-0112710.877084162055
2019-03-0114023.637920456307
2019-04-0113123.225976092393
2019-05-0112736.092663884412
2019-06-0113486.424713964981
2019-07-0113042.185530032835
2019-08-0114374.363711140026
2019-09-0114381.914900789503
2019-10-0114887.574921959804
2019-11-0115353.860882814975
2019-12-0115823.113382461013
2020-01-0116746.583423790293
2020-02-0115977.575663594502
2020-03-0116982.22099365565
2020-04-0117909.601472481983
2020-05-0118010.935740724508
2020-06-0117851.282016707006
2020-07-0117058.946474201224
2020-08-0117070.40810134775
2020-09-0118258.77657243411
2020-10-0117116.861401959264
2020-11-0117441.76482089522
2020-12-0117933.873153498156
2021-01-0117646.051469448023
2021-02-0118184.54568132631
2021-03-0118480.99729640442
2021-04-0119218.317028606874
2021-05-0120391.78538440275
2021-06-0122252.479419637137
2021-07-0124492.755577430034
2021-08-0126587.334227789728
2021-09-0126360.191746280027
2021-10-0129839.806905293248
2021-11-0129858.752300753094
2021-12-0131142.656805172563
2022-01-0127937.51390565058
2022-02-0128965.958967374816
2022-03-0132074.352249512882
2022-04-0134819.41195110604
2022-05-0132583.922708180227
2022-06-0133723.950081242714
2022-07-0136341.650878837114
2022-08-0133900.12203261844
2022-09-0132760.29692356443
2022-10-0135328.10593240337
2022-11-0138107.213408755335
2022-12-0140662.212363724626
2023-01-0140572.60940797325
2023-02-0142615.341050828945
2023-03-0147109.91700433519
2023-04-0148742.86176603448
2023-05-0148394.29345810775
2023-06-0147458.41789092575
2023-07-0147180.911671307505
2023-08-0155470.432373028765
2023-09-0155976.22723687138
2023-10-0158920.24730146101
2023-11-0160437.69931432501
2023-12-0160826.78784528152
2024-01-0168452.81517789119
2024-02-0171409.84756035895
2024-03-0178359.84115533202
2024-04-0178229.24602719776
2024-05-0181063.70642053382
2024-06-0187856.06893157409
2024-07-0179783.64493227526
2024-08-0182176.42815245313
2024-09-0169496.56488292284
2024-10-0167319.93446646124
2024-11-0166454.51419556233
2024-12-0154895.73290363468
2025-01-0153512.381928385046
2025-02-0156659.40763614054
2025-03-0141998.705510345804
2025-04-0138879.7944997674
2025-05-0141532.217285482155
2025-06-0138986.45505356625
2025-07-0128230.18992590395
2025-08-0132298.191085550934
2025-09-0131199.22330620748
2025-10-0128708.004935241806
2025-11-0128579.904396545327
2025-12-0129692.35644311999
2026-01-0133528.63047039866
2026-02-0121574.827569932782
2026-03-0120927.5827428348
2026-04-0123209.794971716747
Annual Return Matrix
YearAnnual Return
20170.3491323997098701
20180.19472991322208677
20190.3539677503100931
20200.13339724743278358
20210.7365271036891394
20220.3056757687086906
20230.4959045341946524
2024-0.09750728505889572
2025-0.4591135800073445
2026-0.21832425068119898
Total Factor Risk
0.5318324340975388
VTI.US Exposure
-0.009669342143701711
VEA.US Exposure
-0.0001469139867468515
VWO.US Exposure
-0.0005497083903430865
QQQ.US Exposure
-0.004786537992624458
VTV.US Exposure
0.003173619817436724
IJR.US Exposure
0.010012177994952569
QUAL.US Exposure
0.3583223268987832
SHV.US Exposure
0.3113298828458774
TLT.US Exposure
0.00005696705417059256
LQD.US Exposure
0.0005698915476547869
HYG.US Exposure
0.013609100817788017
GLD.US Exposure
0.020851167303817218
USO.US Exposure
0.00007678659815049258
VNQ.US Exposure
-0.00027906469513469816
BTC-USD.CC Exposure
0.007072002315123631
CPER.US Exposure
0.007577946400432429
VIX.INDX Exposure
0.016332253567657825
UUP.US Exposure
0.007849873369234775
TIP.US Exposure
0.0029408124999617887
Idiosyncratic Exposure
0.2556567581775093
Value Score
45.9
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
100
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
53.2%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →10.2x
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →37.36%
Market Cap$140.6B
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$717
Avg Yield on Cost
7.17%
Annual Income Simulation Table
Historical Realised Yields
YearAnnual PayoutYield on CostQuality
2026$717.267.17%Solid

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-0.1%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-22.1%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
50.0% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
0.27
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Novo Nordisk A/S a high-risk investment?

Novo Nordisk A/S (NOV.XETRA) has an annualized volatility of 53.2% and experienced a maximum drawdown of 76.2% over the last 10 years. Its primary macro risk driver is QUAL.US.

What is the 10-year return of NOV.XETRA?

Over the past 10 years, NOV.XETRA has generated a Compound Annual Growth Rate (CAGR) of 8.3%. It has had a positive return in 70% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Novo Nordisk A/S

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest